A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox Foundation, found that an overwhelming 84% of patients with Parkinson's ...
Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...
Eagles guitarist Steuart Smith announced that he is retiring from the band after being diagnosed with Parkinsonism. "I find ...
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.
Scientists from the Institute of Nano Science and Technology (INST) Mohali, an autonomous institute of the Department of Science and Technology, announced a targeted ...
A study by researchers at Ireland's Maynooth University showed that sleep problems are very common in people with Parkinson’s disease and such problems are associated with poorer quality of life in pa ...
Brain implants that could help repair the pathways damaged by Parkinson’s disease are being developed by University of ...
Clinically Meaningful Benefit Observed at Both ATH434 Doses Studied –– Achieved Statistical Significance with Up to 48% Slowing of Clinical ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company with a market capitalization of $3.06 billion, focuses on developing and commercializing innovative medicines to address unmet ...
A compelling new study is building on a growing body of evidence showing a common exercise supplement used to build muscle ...